UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 313

Sortiert nach

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Viruses, 2022-08, Vol.14 (8), p.1812

2022

Volltextzugriff (PDF)

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Journal of hepatology, 2014-11, Vol.61 (5), p.984-993

2014

Volltextzugriff (PDF)

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatology international, 2024-06, Vol.18 (3), p.1066-1066

2024

Volltextzugriff (PDF)

Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus

The Journal of pathology, 2017-10, Vol.243 (2), p.176-192

2017

Volltextzugriff (PDF)

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatology international, 2021-12, Vol.15 (6), p.1456-1465

2021

Volltextzugriff (PDF)

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

American journal of epidemiology, 2007-07, Vol.166 (2), p.196-203

2007

Volltextzugriff (PDF)

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

PloS one, 2012-07, Vol.7 (7), p.e41931-e41931

2012

Volltextzugriff (PDF)

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Journal of hepatology, 2009-02, Vol.50 (2), p.289-295

2009

Volltextzugriff (PDF)

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Cellular microbiology, 2017-04, Vol.19 (4), p.np-n/a

2017

Volltextzugriff (PDF)

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

PloS one, 2013-11, Vol.8 (11), p.e80053-e80053

2013

Volltextzugriff (PDF)

Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1

Journal of gastroenterology and hepatology, 2017-12, Vol.32 (12), p.1998-2005

2017

Volltextzugriff (PDF)

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Cell communication and signaling, 2023-07, Vol.21 (1), p.172-172, Article 172

2023

Volltextzugriff (PDF)

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Cancers, 2018-11, Vol.10 (11), p.460

2018

Volltextzugriff (PDF)

Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan

International journal of cancer, 2006-10, Vol.119 (8), p.1946-1952

2006

Volltextzugriff (PDF)

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2021-05, Vol.10 (6), p.1294

2021

Volltextzugriff (PDF)

Detection of Hepatitis B Virus–Host Junction Sequences in Urine of Infected Patients

Hepatology communications, 2021-10, Vol.5 (10), p.1649-1659

2021

Volltextzugriff (PDF)

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan

Journal of the Formosan Medical Association, 2021-03, Vol.120 (3), p.983-990

2021

Volltextzugriff (PDF)

Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas

The journal of pathology. Clinical research, 2019-07, Vol.5 (3), p.199-212

2019

Volltextzugriff (PDF)

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus

Journal of gastroenterology and hepatology, 2016-07, Vol.31 (7), p.1323-1329

2016

Volltextzugriff (PDF)

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

Liver international, 2016-08, Vol.36 (8), p.1101-1107

2016

Volltextzugriff (PDF)

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

Gut, 2013-08, Vol.62 (8), p.1193-1203

2013

Volltextzugriff (PDF)

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients

Diagnostics (Basel), 2021-08, Vol.11 (8), p.1475

2021

Volltextzugriff (PDF)

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Cancers, 2023-01, Vol.15 (3), p.854

2023

Volltextzugriff (PDF)

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma

PloS one, 2012-04, Vol.7 (4), p.e35789-e35789

2012

Volltextzugriff (PDF)

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Hepatology (Baltimore, Md.), 2001-06, Vol.33 (6), p.1527-1532

2001

Volltextzugriff (PDF)

26 – 50 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(284)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(16)
Gastroenterology
(14)
Journal Of Gastroenterology And Hepatology
(13)
Plos One
(13)
Journal Of Hepatology
(11)
Cancer Research
(9)
Journal Of Medical Virology
(9)
Liver International
(8)
Hepatology International
(7)
Scientific Reports
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients

Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatocellular carcinoma‐associated single‐nucleotide variants and deletions identified by the use of genome‐wide high‐throughput analysis of hepatitis B virus

Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation

Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer

Fucosyl-Agalactosyl IgG₁ Induces Cholangiocarcinoma Metastasis and Early Recurrence by Activating Tumor-Associated Macrophage

Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan

Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma

Detection of Hepatitis B Virus–Host Junction Sequences in Urine of Infected Patients

Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan

Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas

Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III

Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Suchergebnisse filtern